Abstract | UNLABELLED: CONCLUSION:
Terlipressin appears an effective rescue treatment in patients with refractory vasodilatory septic shock. Further studies are required to assess its efficacy and safety in neonatal population.
|
Authors | Luca Filippi, Chiara Poggi, Lisa Serafini, Patrizio Fiorini |
Journal | Acta paediatrica (Oslo, Norway : 1992)
(Acta Paediatr)
Vol. 97
Issue 4
Pg. 500-2
(Apr 2008)
ISSN: 0803-5253 [Print] Norway |
PMID | 18307552
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Vasoconstrictor Agents
- Lypressin
- Terlipressin
|
Topics |
- Abdominal Neoplasms
(congenital, surgery)
- Fatal Outcome
- Humans
- Infant, Newborn
- Lypressin
(administration & dosage, analogs & derivatives, therapeutic use)
- Male
- Neuroblastoma
(congenital, surgery)
- Shock, Septic
(drug therapy, physiopathology)
- Terlipressin
- Vasoconstrictor Agents
(administration & dosage, therapeutic use)
- Vasodilation
(drug effects)
|